Session Details
[28-08-am]Pharmacotherapy (Basic Research)
Fri. Mar 28, 2025 8:30 AM - 9:54 AM JST
Fri. Mar 28, 2025 11:30 PM - 12:54 AM UTC
Fri. Mar 28, 2025 11:30 PM - 12:54 AM UTC
Room 8 (Fukuoka International Congress Center: 409+410 [4F])
Chair: Kensuke Nakajima, Kaori Tabata
[28-08-am01S]Effect of esomeprazole on oxaliplatin-induced peripheral neuropathy in rats
○Kanade Koriyama1, Yasuhito Tsukushi1, Shinji Kobuchi1, Toshiyuki Sakaeda1, Yukako Ito1 (1. Kyoto Pharm. Univ.)
[28-08-am02]Effects of Kumazasa processed food on behavior and immune system in LPS-induced inflammation model mice
○Yoshikazu Matsuda1, Hideki Iwasaki1, Natsuki Kawaharada1, Aoi Chiba1, Hiroaki Sano2, Takanari Tominaga2, Akio Ogawa2, Ken-ichi Sako1, Tomoji Maeda1, Tohru Takahashi1, Takahiro Kawase3, Takamitsu Tsukahara3 (1. Nihon Pharmaceutical University, 2. Raffinee International Inc, 3. Kyoto Institute of Nutrition & Pathology)
[28-08-am03]Establishment of a Secretion Evaluation System for Ghrelin-Producing Cells Using the HiBit System
○Takuya Ensho1, Yoko Ueda1, Hiroshi Iwakura1 (1. Department of Pharmacotherapeutics, Sch. Pharm. Sci., Wakayama Med. Univ.)
[28-08-am04S]Pharmacokinetic study on dose adjustment of trifluridine+tipiracil chemotherapy in rats with chronic kidney disease
○Rei Nakayama1, Nanaho Isohashi1, Hikari Uchida1, Karin Hisakawa1, Takumi Tanaka1, Shinji Kobuchi1, Toshiyuki Sakaeda1, Yukako Ito1 (1. Kyoto Pharm. Univ.)
[28-08-am05S]Population pharmacokinetic study on dose adjustment of capecitabine in rats with chronic kidney disease
○Hikari Uchida1, Nanaho Isohashi1, Rei Nakayama1, Karin Hisakawa1, Takumi Tanaka1, Shinji Kobuchi1, Toshiyuki Sakaeda1, Yukako Ito1 (1. Kyoto Pharm. Univ.)
[28-08-am06S]NZ-419, an endogenous antioxidant, attenuates mycotoxin-induced nephrotoxicity in human proximal tubular cells
○Ebenezer Ofori-Attah1, Mai Hashimoto1, Mayu Oki1, Hisao Kansui1, Hitoshi Maeda2, Daisuke Kadowaki1,3 (1. Grad. Sch. Pharm. Sci., Sojo Univ., 2. Grad. Sch. Pharm. Sci., Kumamoto Univ., 3. DDS Res. Inst., Sojo Univ.)
[28-08-am07S]The therapeutic effects of a Liver X receptor ß ligand, Ouabagenin, on crescentic glomerulonephritis
○Ryohei Yamagishi1, Katsuki Matayoshi1, Madoka Kawakami1, Takuya Kumagai1, Sei Yonezawa1, Tadashi Tamura2, Tomohiro Asai1 (1. Grad. of Master, Sch. of Pharm. Sci., Univ. of Shizuoka, 2. Wakayama Medical University)